NCT06532409View on ClinicalTrials.gov

Comparison of Efficacy of Oral Amoxicillin Versus Intravenous Ceftriaxone

NANot yet recruitingINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Community-acquired Pneumonia
Interventions
DRUG

Amoxicillin/CA

Patients will receive IV amoxicillin/CA at a dose of 100 mg per kg per day in 3 divided doses for a maximum period of 7 days.

DRUG

IV ceftriaxone

Patients will receive IV ceftriaxone at a dose of 75 mg per kg per day in 2 divided doses for a maximum period of 7 days.

Trial Locations (1)

54000

Children Hospital, Lahore

All Listed Sponsors
lead

RESnTEC, Institute of Research

OTHER

NCT06532409 - Comparison of Efficacy of Oral Amoxicillin Versus Intravenous Ceftriaxone | Biotech Hunter | Biotech Hunter